A total of 130 foreign and domestic drug makers, dissatisfied with what they considered to be unreasonable slashing of payments for their products, filed appeals in respect of over 500 medicines. The BNHI responded in early November, raising payments for 39 items and recalculating the numbers for 30 others.
此外，有 130 家本地和外商藥廠不滿自己的藥品遭到不合理砍價，已針對五百多項藥品提出申覆，健保局已於 11 月初公佈申覆結果，其中只有 39 項藥品獲得調升，另有 30 項藥品重新計價。